Patent · US Active

Use of N-myristoyltransferase on non-tumor tissue for cancer diagnosis

US7892758B2 · kind B2 · utility

2Cited by

0References

14Claims

0Family size

Assignee

University of Saskatchewan · CA

Inventors

Rajendra Kumar Sharma · Hyderabad, IN
Anuraag Shrivastav · Saskatoon, CA

Key dates

Filing date	Sep 26, 2006
Grant date	Feb 22, 2011
Priority date	—
Expiry date	Jun 5, 2027

Classification

Technology area (CPC G)Physics
CPC primaryG01N2333/91057
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

A diagnostic method and kit are disclosed for detection of cancer. Detection of elevated levels of N-myristoyltransferase (NMT) or NMT activity in blood or bone marrow, and specifically in peripheral blood mononuclear cells, can be used as a marker for cancer. The use of this method for detection of adenocarcinoma, such as colorectal cancer, is exemplified.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.